CSIMarket


Watson Pharmaceuticals Inc  (WPI)
Other Ticker:  
 
    Sector  Consumer Non Cyclical    Industry Legacy
   Industry Legacy
   Sector  Consumer Non Cyclical


 

Watson Pharmaceuticals Inc

WPI's Financial Statements and Analysis



Watson Pharmaceuticals Inc reported in III. Quarter net earnings per share of $0.60 an increase by 11.11 % year on year from $0.54 and an improvement compare to net loss per share of $-0.49 realized in previous quarter.


III. Quarter
Earnings Per Share Revenues
$ 0.6 $  1,285 Mill
$+0.06     +11.11 % $+204M     +18.82 %



Watson Pharmaceuticals Inc's Revenue rose by 18.82 % in III. Quarter (Sep 30 2012) year on year, to $1,285 million and declined by -5.17 % sequentially.


Watson Pharmaceuticals Inc is

More on WPI's Income Statement





       
  • Branded pharmaceutical products 9.97% Y/Y,
• Generic pharmaceutical products 14.75% Y/Y,
• Distribution 43.96% Y/Y
   
     


WPI's Segments

Watson Pharmaceuticals Inc's net income of $77 million in III. Quarter increased by 12.63 % from net earnings of $68 million achieved in III. Quarter a year ago.

Sequentially Company turn into Profitability from net loss of $-62.20 million recorded in previous quarter.

More on WPI's Growth



Watson Pharmaceuticals Inc Income Growth by Division
• Generic pharmaceutical products 23.14% Y/Y,
• Distribution 33.65% Y/Y Inventories grew by 30.28 % to $885 million from III. Quarter a year ago, sequentially inventories rose by 1.69 %. WPI's Cash flow In III. Quarter company's net cash flow was $4 million, capital expenditures grew by -2.70%, to $-40 millions compare to same quarter a year ago and fell by 58.80% from II. Quarter (June 30. 2012).

More on WPI's Cash flow Statement


Watson Pharmaceuticals Inc does not pay out common stock dividend.

In trailing twelve-month period Watson Pharmaceuticals Inc earned $ 4.25 cash per share, on a free-cash flow basis 329.28 % of net earning per share.

Book value grew by 1.84 % sequentially to $28.83 per share, 103.84% of net income per share in trailing twelve-month period were contributed to shareholder value.
Tangible Book value grew to $ 2.91 per share from $ 1.44.

Company issued 2.20 million shares or 1.75 % in III. Quarter.
Interest Coverage Ratio was 4.86. Debt Coverage Ratio was 0.29.

More on WPI's Dividends

 Market Capitalization (Millions) -
 Shares Outstanding (Millions) 128
 Total Debt (Millions $) 1,221
 Revenue (TTM) (Millions $) 5,709
 Net Income (TTM) (Millions $) 164
 Cash Flow (TTM) (Millions $) 59
 Capital Exp. (TTM) (Millions $) -124
 Dividend TTM ($) 0 $
 Dividend Yield TTM (%) -
 Employees (TTM) $ 6,686




Watson Pharmaceuticals Inc does not pay out common stock dividend.

In trailing twelve-month period Watson Pharmaceuticals Inc earned $ 4.25 cash per share, on a free-cash flow basis 329.28 % of net earning per share.

Book value grew by 1.84 % sequentially to $28.83 per share, 103.84% of net income per share in trailing twelve-month period were contributed to shareholder value.
Tangible Book value grew to $ 2.91 per share from $ 1.44.

Company issued 2.20 million shares or 1.75 % in III. Quarter.
Interest Coverage Ratio was 4.86. Debt Coverage Ratio was 0.29.

More on WPI's Balance Sheets

 Market Capitalization (Millions) -
 Shares Outstanding (Millions) 128
 Total Debt (Millions $) 1,221
 Revenue (TTM) (Millions $) 5,709
 Net Income (TTM) (Millions $) 164
 Cash Flow (TTM) (Millions $) 59
 Capital Exp. (TTM) (Millions $) -124
 Dividend TTM ($) 0 $
 Dividend Yield TTM (%) -
 Employees (TTM) $ 6,686


   



       
Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

NVFY's Profile

Stock Price

NVFY's Financials

Business Description

Fundamentals

Charts & Quotes

NVFY's News

Suppliers

NVFY's Competitors

Customers & Markets

Economic Indicators

NVFY's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Cryptocurrencies

Sectors & Industries

Commodities

Currencies

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.    Copyright © 2021 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071